{
  "id": 9841181,
  "title": "AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?",
  "url": "https://urgent.news/2026/09/25/abbvie-vs-pfizer-which-healthcare-stock-makes-your-portfolio",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-25T21:02:01.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/better-buy/2026/09/25/abbvie-vs-pfizer-which-healthcare-stock-makes-your-portfolio-healthier-in-2026/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Comparing AbbVie (NYSE:ABBV) and Pfizer Inc (NYSE:PFE) as potential additions to a 2026 investment portfolio requires a thorough examination of their respective pipelines and patent longevity. In recent years, AbbVie has successfully transitioned from its Humira dominance to focus on new immunology leaders, positioning itself for long-term growth. On the other hand, Pfizer is currently navigating the post-pandemic landscape by strategically acquiring new oncology and metabolic assets to bolster its future prospects.\n\nDespite both companies offering attractive dividends, they also encounter unique regulatory challenges and patent expirations that could significantly impact their trajectories over the coming decade. AbbVie, a research-driven biopharmaceutical company with a specialization in immunology, oncology, and aesthetics, depends heavily on three major wholesale distributors in the United States: McKesson Corp (NYSE:MCK), Cardinal Health (NYSE:CAH), and Cencora (NYSE:COR). This level of customer concentration introduces a degree of risk, as any disruption with one of these partners could potentially disrupt its distribution channels.",
  "summary": "AbbVie pivots toward newer immunology drugs while Pfizer leans on acquisitions to offset pandemic decline, but their financial profiles and valuations tell starkly different stories.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?",
        "url": "https://urgent.news/2026/09/25/abbvie-vs-pfizer-which-healthcare-stock-makes-your-portfolio-9842138",
        "published": "2026-09-25T21:22:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}